01 Development of Safety Cannulas With Advanced Needle Protection The need to reduce accidental needlestick injuries and blood exposure is encouraging healthcare providers to adopt cannulas with integrated needle-shielding mechanisms. This transition is improving user safety by automatically covering or retracting the needle after vascular access while also supporting more controlled insertion procedures. For example, BD’s Venflon Pro Safety IV Cannula uses a passive safety system that fully shields the needle tip as it is withdrawn, helping protect healthcare workers from needlestick injuries.
02 Adoption of Microcannulas for Minimally Invasive Aesthetic Procedures The demand for less traumatic techniques in dermal filler procedures is encouraging practitioners to use flexible, blunt-tipped microcannulas for facial and soft-tissue applications. This transition can reduce tissue trauma and improve patient comfort while allowing fillers to be distributed through a single entry point in selected procedures. For example, a clinical study involving 95 patients reported lower pain and less bruising with blunt-tip microcannulas than with hypodermic needles during filler injections.
01 Fluid Delivery and Disposable Clinical Use Drive Market The need for reliable fluid and medication administration creates requirements for cannulas that provide vascular access during clinical treatment. WHO identifies intravenous administration of drugs and fluids among the major uses of injection procedures and estimates that at least 16 billion injections are administered globally each year. For example, a peripheral intravenous cannula can provide access for fluids, antibiotics, or other medicines during hospital treatment. This routine clinical requirement supports consistent procurement of cannulas and encourages suppliers to provide devices suited to different patient and treatment needs.The need for infection-controlled clinical procedures creates requirements for sterile, single-use cannulas across healthcare facilities. WHO guidance recommends using a new, sealed needle, syringe, or intravenous cannula for each patient injection and states that injection devices should not be reused between patients. For example, hospitals can use individually packaged sterile IV cannulas during emergency care, surgery, and routine infusion procedures. This infection-prevention requirement supports recurring replacement volumes and creates continued supply requirements for disposable cannula manufacturers.
01 Skilled Workforce and Infection Risks Restrain Market Expansion Shortage of skilled healthcare professionals can limit the safe insertion, management, and removal of cannulas during clinical procedures. WHO projects a global health workforce shortage of 11 million workers by 2030, while CDC guidance recommends that only trained and competent personnel perform intravascular catheter insertion and maintenance. This workforce constraint can reduce effective cannula utilization and slow market adoption.Product-related infection risks can arise from improper cannula insertion, handling, maintenance, or inadequate aseptic practices. CDC guidance emphasizes hand hygiene, aseptic technique, appropriate catheter care, and trained personnel to reduce intravascular catheter-related infections. These infection-control requirements can increase procedural complexity and healthcare costs, limiting the adoption of cannula products.
01 Antimicrobial Cannula Technologies and Strategic Medical Device Partnerships Offers Growth Opportunities Cannula manufacturers, medical-device companies, and biomaterial suppliers can develop antimicrobial and antithrombogenic surfaces that help reduce microbial colonization and catheter-related complications. Teleflex reports that several of its vascular-access catheters use antimicrobial and antithrombogenic protection technologies, creating revenue through differentiated cannula products and premium vascular-access solutions.Cannula manufacturers, pharmaceutical companies, and Medtech/oem companies can collaborate on customized delivery components and integrated medical-device systems. BD provides OEM contract manufacturing and customized kits for medtech companies, including injection products and vascular-access devices, creating revenue through long-term supply agreements and co-developed products.
01 Product Quality Requirements and Manufacturing Costs Hinders Growth Cannulas must maintain consistent dimensions, flexibility, flow characteristics, connection integrity, and mechanical performance across production batches. ISO 7864 specifies requirements and test methods for sterile, single-use hypodermic needles, including dimensions, cleanliness, freedom from defects, and mechanical strength. Meeting these requirements increases inspection, testing, and process-control needs for manufacturers, while quality deviations can lead to rejected batches and higher production costs.Producing precision cannulas at large volumes requires specialized molding, extrusion, forming, assembly, and inspection equipment. The U.S. Food and Drug Administration's guidance on medical-device manufacturing emphasizes process validation where results cannot be fully verified through subsequent inspection and testing, requiring manufacturers to demonstrate that processes consistently produce conforming products. These validation and production requirements can increase capital and operating expenditure, particularly for smaller manufacturers, limiting capacity expansion.
March 2026 BD (Becton, Dickinson and Company) expanded its vascular access device portfolio with advanced cannula and catheter solutions designed to improve patient safety, reduce complications, and support clinical procedures across hospitals and healthcare facilities.
January 2026 Teleflex expanded its medical device portfolio with enhanced cannula and vascular access solutions, focusing on minimally invasive procedures, improved device performance, and better patient outcomes.
October 2025 Terumo expanded its cannula and cardiovascular device portfolio with advanced solutions designed for cardiac surgery, extracorporeal procedures, and vascular access applications.
August 2025 B. Braun expanded its infusion therapy and cannula product portfolio with improved safety cannula technologies designed to support infection prevention, medication delivery, and hospital care applications.